Table 2.
HC (22) | SS (53) | PMF (38) | P | |
---|---|---|---|---|
Leukocytes* | 6.3 ± 1.4 | 6.1 ± 1.7 | 6.4 ± 1.4 | 0.198a |
Monocytes* | 0.5 ± 0.1 | 0.56 ± 0.2 | 0.6 ± 0.2 |
0.012b HC vs. SS; = nsc HC vs. PMF; = 0.008c SS vs. PMF; = 0.032c |
Lymphocytes* | 2.2 ± 0.6 | 1.7 ± 0.5 | 1.6 ± 0.4 |
0.001a HC vs. SS; = 0.001d HC vs. PMF; < 0.0001c SS vs. PMF; = nsd |
Neutrophils* | 3.4 ± 0.9 | 3.7 ± 1.4 | 4 ± 1.2 | 0.071a |
Platelets* | 222.9 ± 40.6 | 239.8 ± 59.7 | 242.5 ± 40.6 | 0.334b |
NLR | 1.6 ± 0.5 | 2.4 ± 1 | 2.7 ± 1.5 |
< 0.0001a HC vs. SS; = 0.002d HC vs. PMF; < 0.0001d SS vs. PMF; = nsd |
PLR | 108.3 ± 37.1 | 154.5 ± 54.8 | 160.5 ± 53.5 |
< 0.0001a HC vs. SS; = 0.001c HC vs. PMF; < 0.0001d SS vs. PMF; nsd |
LMR | 4.5 ± 1.5 | 3.1 ± 0.9 | 2.7 ± 1 |
< 0.0001a HC vs. SS; < 0.0001c HC vs. PMF; < 0.0001d SS vs. PMF; = 0.044d |
SII | 369.5 ± 157 | 567.3 ± 290.7 | 668.9 ± 424.7 |
< 0.0001a HC vs. SS; = 0.002d HC vs. PMF; < 0.0001d SS vs. PMF; nsd |
SIRI | 0.8 ± 0.4 | 1.3 ± 0.7 | 1.8 ± 1.2 |
< 0.0001a HC vs. SS; = 0.002d HC vs. PMF; < 0.0001d SS vs. PMF; = 0.036d |
AISI | 191.5 ± 109.6 | 330.8 ± 219.8 | 447.1 ± 314.1 |
< 0.0001a HC vs. SS; = 0.006d HC vs. PMF; < 0.0001d SS vs. PMF; = 0.044d |
NLR (neutrophil/lymphocyte ratio), PLR (platelet/lymphocyte ratio), LMR (lymphocyte/monocyte ratio), SII (neutrophil x platelet/lymphocyte ratio), SIRI (neutrophil x monocyte/lymphocyte ratio) and AISI (neutrophil x monocyte x platelet/lymphocyte ratio). *(× 103 cell/µl). Data represent mean ± standard deviation. aKruskal–Wallis test, bANOVA, cStudent´s T-test, dMann–Whitney-U test. P, p value; ns non-significant.